Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Flexagen Joint Care "From The Makers of Advil " Hitting Shelves Now

This article was originally published in The Tan Sheet

Executive Summary

Flexagen, a glucosamine/chondroitin joint care supplement, will be backed by a national TV and print ad campaign breaking in July, Whitehall-Robins announced at the National Association of Chain Drug Stores Marketplace in New Orleans June 25-28.
Advertisement

Related Content

Hauser Non-Botanical Supplement Deal Could Help Offset Herbal Declines
Hauser Non-Botanical Supplement Deal Could Help Offset Herbal Declines
Hauser Non-Botanical Supplement Deal Could Help Offset Herbal Declines
Weider's Schiff Move Free FY 2000 Sales Jump 55% To $110 Mil.
Perrigo
McNeil Motrin Migraine Pain, Aflexa Supplement National Ads Breaking Soon
McNeil Motrin Migraine Pain, Aflexa Supplement National Ads Breaking Soon
Weider Soy Powder With Once-Daily Dosing Joining Schiff Line April 1
Supplement Claims For Drug/Therapy Augmentation Clarified By FDA
Nature's Life Relabeling Zinc Lozenges As Food Following "Courtesy" Letter

Topics

Advertisement
UsernamePublicRestriction

Register

PS091374

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel